December 16, 2020

BioLineRx Announces Final Results from Phase 2a COMBAT/KEYNOTE-202 Triple Combination Study of Motixafortide in Second Line Metastatic Pancreatic Cancer (PDAC)

November 23, 2020

BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update

November 18, 2020

BioLineRx to Report Third Quarter 2020 Results on November 23, 2020